Analyst Ratings for Haemonetics Corp. (HAE)Updated: 2017-07-27
An average rating of Hold has been given to Haemonetics Corp. (NYSE:HAE) by analysts covering the stock. About 30 days ago, HAE was issued an average rating of Hold.
9 analysts issued ratings on the stock, where 2 gave HAE a buy rating, 0 issued an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.
Many analysts weighed in on price targets for HAE. The most optimistic price target was 50, implying potential capital gains of 26.52 percent. The lowest price target was 38, implying potential capital losses of -3.85 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.
Analysts have revised their earnings estimates downwards for this quarter, by about -1.56 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is 0 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0.32 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -0.88 percent.
People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts revised their estimates downwards. Also over the last month, 2 analysts increased their estimates for the FY earnings, while 1 analysts decreased their estimates.
HAE has traded between a high of 43.62 and a low of 29.75 over the past year. The current market price is above the trailing year's low by 32.84 percent, and 9.4 percent lower than its 52-week high. HAE has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HAE value stock report compares HAE to some of its peers using value stock charts. The market cap of HAE is $2.08 billion. HAE is estimated to release their earnings results for the quarter on 0000-00-00, days from today.